Legis1: FDA Faces Staffing Crisis Threatening U.S. Drug Innovation

The FDA biomedical innovation hearing featured five witnesses: Susan Winckler from the Reagan-Udall Foundation for the FDA, Aaron J. Kowalski from Breakthrough T1D, Dr. Thomas Hwang from Brigham and Women's Hospital and Harvard Medical School, Dr. Cynthia Verst from IQVIA, and Thomas J. Bollyky from the Council on Foreign Relations.